Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
出版年份 2018 全文链接
标题
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-05-16
DOI
10.1038/s41467-018-04356-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas
- (2018) Cecilia Bandini et al. Cancers
- PTPN2 regulates T cell lineage commitment and αβ versus γδ specification
- (2017) Florian Wiede et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
- (2017) Yu Liu et al. NATURE GENETICS
- Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
- (2016) R. L. Boddicker et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
- (2016) Elizabeth C. Townsend et al. CANCER CELL
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
- (2016) John G Doench et al. NATURE BIOTECHNOLOGY
- PTEN opposes negative selection and enables oncogenic transformation of pre-B cells
- (2016) Seyedmehdi Shojaee et al. NATURE MEDICINE
- Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
- (2016) A. J. Aguirre et al. Cancer Discovery
- The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF- B positive feedback loop in peripheral T-cell lymphoma
- (2015) R. L. Boddicker et al. BLOOD
- Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
- (2015) Ramona Crescenzo et al. CANCER CELL
- Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma
- (2015) S. Jain et al. CLINICAL CANCER RESEARCH
- Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma
- (2014) Andre Weilemann et al. BLOOD
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
- (2014) E. R. Parrilla Castellar et al. BLOOD
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
- (2014) T. Velusamy et al. BLOOD
- Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
- (2014) F. Ellin et al. BLOOD
- Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
- (2014) Mamiko Sakata-Yanagimoto et al. NATURE GENETICS
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
- (2014) Teresa Palomero et al. NATURE GENETICS
- A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial
- (2013) Franck Morschhauser et al. EUROPEAN JOURNAL OF CANCER
- t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5
- (2013) Stefan Ehrentraut et al. PLoS One
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- Snakemake--a scalable bioinformatics workflow engine
- (2012) J. Koster et al. BIOINFORMATICS
- Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets
- (2012) M. Travert et al. BLOOD
- Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas
- (2012) G. Vasmatzis et al. BLOOD
- Survival Signals and Targets for Therapy in Breast Implant-Associated ALK- Anaplastic Large Cell Lymphoma
- (2012) M. G. Lechner et al. CLINICAL CANCER RESEARCH
- Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma
- (2011) M. Kleppe et al. HAEMATOLOGICA
- T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice
- (2011) Florian Wiede et al. JOURNAL OF CLINICAL INVESTIGATION
- Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity
- (2010) Melissa G. Lechner et al. CANCER
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
- (2010) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
- (2010) Maria Kleppe et al. NATURE GENETICS
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started